Combined mTOR and MEK Inhibition Is an Effective Therapy in a Novel Mouse Model for Angiosarcoma
Oncotarget - United States
doi 10.18632/oncotarget.25345
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 28, 2018
Authors
Publisher
Impact Journals, LLC